Cargando…

The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

Detalles Bibliográficos
Autores principales:	Lassus, H, Butzow, R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359937/ https://www.ncbi.nlm.nih.gov/pubmed/17437016 http://dx.doi.org/10.1038/sj.bjc.6603741

Ejemplares similares

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: de Graeff, P, et al.
Publicado: (2007)

Clinical Relevance of p53 Immunohistochemical Stain in the Differential Diagnosis Between Pediatric Aplastic Anemia and Refractory Cytopenia of Childhood
por: Park, Sang Hyuk, et al.
Publicado: (2016)

Cytoplasmic Her2/neu Immunohistochemical Staining in Breast Cancer; From a Molecular Point of View
por: Safaei, Akbar, et al.
Publicado: (2019)

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.
por: Jacquemier, J., et al.
Publicado: (1994)

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.
por: Fisher, C. J., et al.
Publicado: (1994)

Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.
por: Ryu, J. W., et al.
Publicado: (2000)

P53 abnormalities and outcomes in colorectal cancer: a systematic review
por: Smith, F M, et al.
Publicado: (2005)

An immunohistochemical analysis of P-glycoprotein in retinoblastoma
por: Sethi, Sumita, et al.
Publicado: (2012)

Subtype classification of malignant lymphoma using immunohistochemical staining pattern
por: Hashimoto, Noriaki, et al.
Publicado: (2022)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Phenazopyridine as an innovative stain for permanent staining of trematodes
por: Fakhar, Mahdi, et al.
Publicado: (2016)

Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma
por: Orachum, Panarat, et al.
Publicado: (2022)

Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011)

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
por: Lassus, H, et al.
Publicado: (2004)

Evaluation of the Pathogenesis of Tumor Development from Endometriosis by Estrogen Receptor, P53 and Bcl-2 Immunohistochemical Staining
por: Esmaili, Haidarali, et al.
Publicado: (2016)

CD34 and p53 Immunohistochemical Stains Differentiate Hypocellular Myelodysplastic Syndrome (hMDS) from Aplastic Anemia and a CD34 Immunohistochemical Stain Provides Useful Survival Information for hMDS
por: Cha, Choong-Hwan, et al.
Publicado: (2014)

A simple and rapid staining method for detection of hemozoin pigment by methylene blue stain
por: Mohapatra, Sarita, et al.
Publicado: (2014)

Does immunohistochemical staining of P53, Ki 67 and cyclin A accurately predict Wilms tumor recurrence and survival?
por: Atwa, Ahmed M, et al.
Publicado: (2022)

P53 staining index and zonal staining patterns in actinic keratoses
por: Javor, Sanja, et al.
Publicado: (2020)

“p53 Polymorphism at Codon 72 and Breast Cancer” - Letter
por: Afzaljavan, Fahimeh, et al.
Publicado: (2017)

Immunohistochemical analysis of PDK1 expression in breast cancer
por: Arsenic, Ruza
Publicado: (2014)

Diagnostic value of IMP3 and p53 immunohistochemical staining in EUS-guided fine-needle aspiration for solid pancreatic tumors
por: Mikata, Rintaro, et al.
Publicado: (2021)

An immunohistochemical study of the expression of p53 protein in colon cancer.
por: Kim, Y. W., et al.
Publicado: (1995)

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.
por: Henry, J. A., et al.
Publicado: (1991)

Functional assessment of p53 in chronic lymphocytic leukemia
por: Le Garff-Tavernier, M, et al.
Publicado: (2011)

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.
por: Buttitta, F., et al.
Publicado: (1997)

Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

Molecular and immunohistochemical analysis of P53 in phaeochromocytoma.
por: Dahia, P. L., et al.
Publicado: (1995)

A pilot study using immunohistochemical staining to characterize dihydropyrimidine dehydrogenase expression in keratinocyte neoplasms
por: Ikediobi, Ogechi, et al.
Publicado: (2023)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases
por: Kulaç, İbrahim, et al.
Publicado: (2017)

C4d staining in allograft biopsies
por: Kulkarni, P., et al.
Publicado: (2012)

Sex differences in cancer risk among germline p53 mutation carriers
por: Chompret, A, et al.
Publicado: (2004)

The Cottage Hospital, Staines
por: Moore, Leslie
Publicado: (1914)

Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms
por: JAMMAL, MILLENA PRATA, et al.
Publicado: (2015)

Quantification of Immunohistochemically Stained Cells in Skin Biopsies
por: Emmanuel, Thomas, et al.
Publicado: (2022)

Merkel cell carcinoma with an unusual immunohistochemical profile
por: Pilloni, L., et al.
Publicado: (2009)

Link between p53 isoforms and angiogenesis: Current prospects
por: Bid, Hemant Kumar
Publicado: (2013)

Gram Staining: A Simple Effective Tool for Diagnosis of Nocardiosis
por: Baikunje, Nandakishore, et al.
Publicado: (2022)

Screening of BRCA1 Mutation Using Immunohistochemical Staining with C‐Terminal and N‐Terminal Antibodies in Familial Ovarian Cancers
por: Kashima, Katsunori, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_690ourqqvulf454v4gdnijj3ov